Preparing for a clinical trial is more than selecting vendors. According to ICH E6(R3), the ultimate responsibility for the sponsor’s trial-related activities remains with the sponsor.

​In this meeting, AuraGxP’s Vendor Management Practice Leader, Jaidyn Nguyen, will explore key considerations for establishing your vendor management and oversight framework: how organization size and structure influence your approach, transfer of obligations, and documentation requirements.

What we will benefit from during the conversation:

• ​Moving from vendor selection to vendor management
• ​Size and structure of company and how that impacts vendor management and oversight
• ​Documentation Needs